Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups
- PMID: 26837631
- PMCID: PMC4970956
- DOI: 10.1007/s10461-016-1300-6
Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups
Abstract
HIV counseling with testing has been part of HIV prevention in the U.S. since the 1980s. Despite the long-standing history of HIV testing with prevention counseling, the CDC released HIV testing recommendations for health care settings contesting benefits of prevention counseling with testing in reducing sexual risk behaviors among HIV-negatives in 2006. Efficacy of brief HIV risk-reduction counseling (RRC) in decreasing sexual risk among subgroups of substance use treatment clients was examined using multi-site RCT data. Interaction tests between RRC and subgroups were performed; multivariable regression evaluated the relationship between RRC (with rapid testing) and sex risk. Subgroups were defined by demographics, risk type and level, attitudes/perceptions, and behavioral history. There was an effect (p < .0028) of counseling on number of sex partners among some subgroups. Certain subgroups may benefit from HIV RRC; this should be examined in studies with larger sample sizes, designed to assess the specific subgroup(s).
Keywords: Counseling; Drug treatment; HIV; Prevention; Substance use.
Similar articles
-
Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.AIDS. 1993 Jun;7(6):887-91. doi: 10.1097/00002030-199306000-00020. AIDS. 1993. PMID: 8363764
-
Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England.AIDS. 1997 Feb;11(2):229-35. doi: 10.1097/00002030-199702000-00014. AIDS. 1997. PMID: 9030371
-
Long-term follow-up after voluntary human immunodeficiency virus/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency department.Acad Emerg Med. 2012 Apr;19(4):386-95. doi: 10.1111/j.1553-2712.2012.01314.x. Acad Emerg Med. 2012. PMID: 22506942 Clinical Trial.
-
Determinants of condom use among intravenous drug users.AIDS. 1993 May;7(5):719-23. doi: 10.1097/00002030-199305000-00017. AIDS. 1993. PMID: 8318179
-
Reframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients.AIDS Patient Care STDS. 2006 Jan;20(1):19-29. doi: 10.1089/apc.2006.20.19. AIDS Patient Care STDS. 2006. PMID: 16426152 Free PMC article. Review.
Cited by
-
Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda.Glob Health Action. 2023 Dec 31;16(1):2242672. doi: 10.1080/16549716.2023.2242672. Glob Health Action. 2023. PMID: 37548558 Free PMC article.
References
-
- Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17. quiz CE1-4. - PubMed
-
- Boone MR, Cook SH, Wilson P. Substance use and sexual risk behavior in HIV-positive men who have sex with men: an episode-level analysis. AIDS Behav. 2013;17(5):1883–7. - PubMed
-
- Beyrer C, Wirtz AL, Baral S, Peryskina A, Sifakis F. Epidemiologic links between drug use and HIV epidemics: an international perspective. J Acquir Immune Defic Syndr. 2010;55(Suppl 1):S10–6. - PubMed
MeSH terms
Substances
Grants and funding
- UG1 DA013034/DA/NIDA NIH HHS/United States
- UG1 DA013720/DA/NIDA NIH HHS/United States
- U10 DA020036/DA/NIDA NIH HHS/United States
- P30 MH043520/MH/NIMH NIH HHS/United States
- UG1 DA013727/DA/NIDA NIH HHS/United States
- U10 DA013732/DA/NIDA NIH HHS/United States
- U10 DA013034/DA/NIDA NIH HHS/United States
- U10 DA015815/DA/NIDA NIH HHS/United States
- U10 DA013038/DA/NIDA NIH HHS/United States
- HHSN271200522071C/DA/NIDA NIH HHS/United States
- U10 DA013036/DA/NIDA NIH HHS/United States
- U10 DA013727/DA/NIDA NIH HHS/United States
- U10 DA015833/DA/NIDA NIH HHS/United States
- U10 DA013720/DA/NIDA NIH HHS/United States
- R21 DA038641/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical